MX9207421A - Nuevos 19-nor-esteroides que tienen en la posicion 11 beta una cadena tiocarbonada, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents
Nuevos 19-nor-esteroides que tienen en la posicion 11 beta una cadena tiocarbonada, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.Info
- Publication number
- MX9207421A MX9207421A MX9207421A MX9207421A MX9207421A MX 9207421 A MX9207421 A MX 9207421A MX 9207421 A MX9207421 A MX 9207421A MX 9207421 A MX9207421 A MX 9207421A MX 9207421 A MX9207421 A MX 9207421A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- contain
- preparation
- hydrogen
- chain
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000732 arylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 150000007857 hydrazones Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000002923 oximes Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- -1 substituted Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9115856A FR2685332A1 (fr) | 1991-12-20 | 1991-12-20 | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9207421A true MX9207421A (es) | 1993-07-01 |
Family
ID=9420274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9207421A MX9207421A (es) | 1991-12-20 | 1992-12-18 | Nuevos 19-nor-esteroides que tienen en la posicion 11 beta una cadena tiocarbonada, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6281204B1 (enExample) |
| EP (1) | EP0623140B1 (enExample) |
| JP (1) | JP3445271B2 (enExample) |
| KR (1) | KR100278465B1 (enExample) |
| CN (1) | CN1036718C (enExample) |
| AT (1) | ATE165365T1 (enExample) |
| AU (1) | AU666916B2 (enExample) |
| CA (1) | CA2124339C (enExample) |
| DE (1) | DE69225243T2 (enExample) |
| DK (1) | DK0623140T3 (enExample) |
| ES (1) | ES2115754T3 (enExample) |
| FI (1) | FI114866B (enExample) |
| FR (1) | FR2685332A1 (enExample) |
| HU (1) | HU221482B (enExample) |
| IL (1) | IL104105A (enExample) |
| MX (1) | MX9207421A (enExample) |
| NZ (1) | NZ246624A (enExample) |
| RU (1) | RU2111213C1 (enExample) |
| WO (1) | WO1993013123A1 (enExample) |
| ZA (1) | ZA929859B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
| FR2706454B1 (fr) * | 1993-06-17 | 1995-09-15 | Roussel Uclaf | Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant. |
| DE19510862A1 (de) * | 1995-03-16 | 1996-09-19 | Schering Ag | Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle |
| DE19526146A1 (de) * | 1995-07-07 | 1997-01-09 | Schering Ag | Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| DE19724187A1 (de) * | 1997-06-02 | 1998-12-03 | Schering Ag | 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln |
| CZ289298A3 (cs) * | 1997-10-14 | 1999-05-12 | Bayer Aktiengesellschaft | Způsob výroby pentafluorpentanolu |
| US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6548491B2 (en) | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| DE19826213A1 (de) * | 1998-06-09 | 1999-12-16 | Schering Ag | Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| FR2780060B1 (fr) * | 1998-06-23 | 2000-08-04 | Hoechst Marion Roussel Inc | Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
| AU1967300A (en) * | 1998-11-20 | 2000-06-13 | Akzo Nobel N.V. | Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| DE19929715A1 (de) | 1999-06-24 | 2000-12-28 | Schering Ag | 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO2001040805A1 (en) * | 1999-11-30 | 2001-06-07 | Akzo Nobel N.V. | Steroid compounds for steroid receptor binding assays |
| WO2005090379A1 (en) * | 2004-03-17 | 2005-09-29 | The Central Science Laboratory, 'csl' | Compounds and sensor for detecion of polycyclic aromatic hydrocarbons |
| EP1623713A1 (en) * | 2004-07-09 | 2006-02-08 | Proskelia SAS | Cominations of pure anti-estrogen with aromatase inhibitors |
| EP1630167A1 (en) * | 2004-07-09 | 2006-03-01 | Proskelia SAS | Polymorphs of 19-Nor steroid derivatives |
| CN100420681C (zh) * | 2005-04-29 | 2008-09-24 | 上海奥锐特国际贸易有限公司 | 多烯紫杉醇三水物的制备方法 |
| DE102008061722A1 (de) | 2008-12-12 | 2010-06-17 | Saltigo Gmbh | Verfahren zur Herstellung von Perfluoralkyl- oder Perfluoralkoxyalkanolen |
| RU2684616C2 (ru) | 2014-01-29 | 2019-04-10 | Умекрин Когнишн Аб | Стероидное соединение для применения в лечении печеночной энцефалопатии |
| TWI748936B (zh) | 2015-01-12 | 2021-12-11 | 瑞典商優鎂奎認知Ａｂ公司 | 新穎化合物 |
| US10278977B2 (en) | 2016-06-06 | 2019-05-07 | Umecrine Cognition Ab | Methods for treating hypersomnolence |
| CN110117217B (zh) * | 2018-12-19 | 2021-09-28 | 浙江普洛家园药业有限公司 | 1-溴代甲基-2,3,5,6-四氟-4-(三氟甲基)苯的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2528434B1 (fr) * | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
| FR2643638B1 (fr) * | 1989-02-24 | 1991-06-14 | Roussel Uclaf | Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| DE69128820T2 (de) * | 1990-08-14 | 1998-06-10 | Hoechst Marion Roussel Inc | Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon |
| FR2685332A1 (fr) * | 1991-12-20 | 1993-06-25 | Roussel Uclaf | Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments. |
-
1991
- 1991-12-20 FR FR9115856A patent/FR2685332A1/fr active Granted
-
1992
- 1992-12-15 IL IL104105A patent/IL104105A/xx not_active IP Right Cessation
- 1992-12-17 EP EP93902339A patent/EP0623140B1/fr not_active Expired - Lifetime
- 1992-12-17 RU RU94031162/04A patent/RU2111213C1/ru not_active IP Right Cessation
- 1992-12-17 AU AU33570/93A patent/AU666916B2/en not_active Ceased
- 1992-12-17 DK DK93902339T patent/DK0623140T3/da active
- 1992-12-17 JP JP51147893A patent/JP3445271B2/ja not_active Expired - Fee Related
- 1992-12-17 NZ NZ246624A patent/NZ246624A/en unknown
- 1992-12-17 CA CA002124339A patent/CA2124339C/fr not_active Expired - Fee Related
- 1992-12-17 AT AT93902339T patent/ATE165365T1/de not_active IP Right Cessation
- 1992-12-17 US US08/244,735 patent/US6281204B1/en not_active Expired - Fee Related
- 1992-12-17 KR KR1019940702134A patent/KR100278465B1/ko not_active Expired - Fee Related
- 1992-12-17 DE DE69225243T patent/DE69225243T2/de not_active Expired - Fee Related
- 1992-12-17 HU HU9402134A patent/HU221482B/hu not_active IP Right Cessation
- 1992-12-17 WO PCT/FR1992/001193 patent/WO1993013123A1/fr not_active Ceased
- 1992-12-17 ES ES93902339T patent/ES2115754T3/es not_active Expired - Lifetime
- 1992-12-18 MX MX9207421A patent/MX9207421A/es not_active IP Right Cessation
- 1992-12-18 ZA ZA929859A patent/ZA929859B/xx unknown
- 1992-12-19 CN CN92115248A patent/CN1036718C/zh not_active Expired - Fee Related
-
1994
- 1994-06-17 FI FI942944A patent/FI114866B/fi not_active IP Right Cessation
-
2001
- 2001-06-26 US US09/891,433 patent/US6596885B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69225243D1 (de) | 1998-05-28 |
| KR100278465B1 (ko) | 2001-02-01 |
| RU2111213C1 (ru) | 1998-05-20 |
| FR2685332B1 (enExample) | 1995-06-02 |
| EP0623140B1 (fr) | 1998-04-22 |
| FR2685332A1 (fr) | 1993-06-25 |
| CA2124339A1 (fr) | 1993-07-08 |
| AU666916B2 (en) | 1996-02-29 |
| AU3357093A (en) | 1993-07-28 |
| RU94031162A (ru) | 1996-04-20 |
| CN1036718C (zh) | 1997-12-17 |
| US6281204B1 (en) | 2001-08-28 |
| FI114866B (fi) | 2005-01-14 |
| ES2115754T3 (es) | 1998-07-01 |
| ATE165365T1 (de) | 1998-05-15 |
| FI942944L (fi) | 1994-06-17 |
| EP0623140A1 (fr) | 1994-11-09 |
| HUT68068A (en) | 1995-05-29 |
| IL104105A (en) | 1997-07-13 |
| DE69225243T2 (de) | 1998-10-29 |
| NZ246624A (en) | 1995-12-21 |
| ZA929859B (en) | 1993-12-20 |
| IL104105A0 (en) | 1993-05-13 |
| HU221482B (en) | 2002-10-28 |
| HU9402134D0 (en) | 1994-09-28 |
| FI942944A0 (fi) | 1994-06-17 |
| US20020072624A1 (en) | 2002-06-13 |
| DK0623140T3 (da) | 1999-02-15 |
| CA2124339C (fr) | 2005-02-15 |
| WO1993013123A1 (fr) | 1993-07-08 |
| US6596885B2 (en) | 2003-07-22 |
| CN1075722A (zh) | 1993-09-01 |
| JP3445271B2 (ja) | 2003-09-08 |
| JPH07502281A (ja) | 1995-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9207421A (es) | Nuevos 19-nor-esteroides que tienen en la posicion 11 beta una cadena tiocarbonada, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2002101A6 (es) | Un procedimiento para la preparacion de complejos de uno o mas flavanolignanos con uno o mas fosfolipidos | |
| FR2662162B1 (fr) | Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| ES2194707T3 (es) | Mezclas insecticidas sinergicas. | |
| ES2114645T3 (es) | Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida. | |
| SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| ES2076935T3 (es) | Compuesto de pirazolopiridina y procedimientos para su preparacion. | |
| ES2079210T3 (es) | Formulacion farmaceutica de aerosol. | |
| PA8547701A1 (es) | Nucleosidos 4 substituidos. | |
| CO6251270A2 (es) | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met | |
| DK0658101T3 (da) | Aerosolformuleringer fri for overfladeaktivt middel og indeholdende beclomethasondipropionat | |
| MX9303124A (es) | Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen. | |
| ES2078676T3 (es) | Amidas de la glicilserina y composiciones cosmeticas, farmaceuticas o alimenticias que las contienen. | |
| ES2054844T3 (es) | Nuevos esteroides que comprenden un ciclo espiranico con 3, 4 o 6 eslabones en posicion 17, su procedimiento, y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| ES2099551T3 (es) | Nuevos 19-nor-esteroides que tienen en posicion 11 beta una cadena de fenoxialquilsulfonamida o fenoxialquilsulfonilurea, procedimiento y productos intermedios de preparacion, aplicacion como medicamentos y composicion farmaceutica que los contiene. | |
| NO307688B1 (no) | Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat | |
| ES2139246T3 (es) | Derivados de n-(benciloxi sustituido en orto)imina y su uso como fungicidas, acaricidas o insecticidas. | |
| ES2148305T3 (es) | Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep. | |
| NO892338L (no) | Middel for insekt- og middbekjempelse. | |
| AR006301A1 (es) | Derivados de oxazolidin-2-ona, procedimiento para prepararlos, medicamento constituido por dicho derivado y composicion farmaceutica que comprende a dicho derivado | |
| MX9302915A (es) | Nuevos derivados de taxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR053299A1 (es) | 11beta-halogenesteroides, su obtencion y uso para la preparacion de medicamentos y preparados farmaceuticos que contienen 11beta- halogenesteroides | |
| ES2123808T3 (es) | Derivado de acilfenilglicina y agente profilactico y curativo para enfermedades causadas por una actividad acrecentada de colagenasa, que contiene dicho compuesto como ingrediente activo. | |
| ES2118954T3 (es) | Nuevos derivados perhidroisoindol y su preparacion. | |
| AR003093A1 (es) | Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights | ||
| HC | Change of company name or juridical status |
Owner name: HYTEC FUEL SYSTEMS INC. |
|
| PD | Change of proprietorship |
Owner name: AVENTIS PHARMA S.A. |
|
| MM | Annulment or lapse due to non-payment of fees |